A detailed history of Carmichael Hill & Associates, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 4,168 shares of MDT stock, worth $378,537. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,168
Previous 4,058 2.71%
Holding current value
$378,537
Previous $319,000 17.55%
% of portfolio
0.13%
Previous 0.13%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$76.84 - $91.03 $8,452 - $10,013
110 Added 2.71%
4,168 $375,000
Q4 2023

Jan 23, 2024

SELL
$69.43 - $83.43 $11,317 - $13,599
-163 Reduced 3.86%
4,058 $334,000
Q3 2023

Oct 30, 2023

BUY
$78.22 - $90.4 $15,644 - $18,080
200 Added 4.97%
4,221 $330,000
Q2 2023

Aug 04, 2023

SELL
$79.47 - $91.38 $35,761 - $41,121
-450 Reduced 10.06%
4,021 $354,000
Q3 2021

Nov 12, 2021

SELL
$122.75 - $135.17 $6,137 - $6,758
-50 Reduced 1.11%
4,471 $561,000
Q2 2021

Aug 03, 2021

SELL
$118.19 - $131.5 $1,772 - $1,972
-15 Reduced 0.33%
4,521 $561,000
Q4 2020

Jan 27, 2021

BUY
$100.57 - $117.14 $2,614 - $3,045
26 Added 0.58%
4,536 $531,000
Q3 2020

Nov 12, 2020

BUY
$90.13 - $108.78 $12,347 - $14,902
137 Added 3.13%
4,510 $469,000
Q4 2019

Jan 30, 2020

BUY
$104.49 - $114.54 $31,347 - $34,362
300 Added 7.37%
4,373 $496,000
Q3 2019

Nov 06, 2019

BUY
$98.02 - $111.18 $3,234 - $3,668
33 Added 0.82%
4,073 $442,000
Q1 2019

Apr 23, 2019

SELL
$82.45 - $93.79 $8,327 - $9,472
-101 Reduced 2.44%
4,040 $368,000
Q4 2018

Jan 16, 2019

SELL
$85.8 - $99.49 $17,160 - $19,898
-200 Reduced 4.61%
4,141 $377,000
Q4 2017

Feb 07, 2018

BUY
$76.93 - $83.5 $333,953 - $362,473
4,341
4,341 $350,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $121B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Carmichael Hill & Associates, Inc. Portfolio

Follow Carmichael Hill & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.